{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:10:53Z","timestamp":1773810653499,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pleural infection, an infection of the pleural space, is frequently treated with antibiotics and thoracic tube drainage. In case of insufficient drainage, an intrapleural fibrinolytic agent is considered before surgical intervention. However, the effectiveness of fibrinolytic monotherapy is still controversial. Therefore, we aimed to examine the association between urokinase monotherapy and treatment failure in patients with pleural infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective observational study, patients with pleural infection underwent chest tube insertion were divided into two groups including patients treated with or without intrapleural instillation of urokinase. The propensity score overlap weighting was used to balance the baseline characteristics between the groups. Treatment failure was defined by the composite primary outcome of in-hospital death and referral for surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 94 patients, 67 and 27 patients were in the urokinase and non-urokinase groups, respectively. Urokinase monotherapy improved the composite outcome between the groups (19.4% vs. 48.1%, p\u2009=\u20090.01). After adjusting using propensity score overlap weighting, urokinase monotherapy improved the composite outcome compared to the non-urokinase group (19.0% vs. 59.5%, p\u2009=\u20090.003).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Urokinase monotherapy can be an important nonsurgical treatment option for patients with pleural infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The participants were retrospectively registered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02559-5","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:03:03Z","timestamp":1689937383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between intrapleural urokinase monotherapy and treatment failure in patients with pleural infection: a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jumpei","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"2559_CR1","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","volume":"153","author":"KR Shen","year":"2017","unstructured":"Shen KR, Bribriesco A, Crabtree T, et al. The American Association for thoracic surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153:e129\u201346. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.01.030.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2559_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.200601-074OC","volume":"174","author":"NA Maskell","year":"2006","unstructured":"Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174:817\u201323. https:\/\/doi.org\/10.1164\/rccm.200601-074OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2559_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1457496919832146","volume":"109","author":"A Lehtom\u00e4ki","year":"2020","unstructured":"Lehtom\u00e4ki A, Nevalainen R, Ukkonen M, et al. Trends in the incidence, etiology, treatment, and outcomes of pleural infections in adults over a decade in a Finnish University Hospital. Scand J Surg. 2020;109:127\u201332. https:\/\/doi.org\/10.1177\/1457496919832146.","journal-title":"Scand J Surg"},{"issue":"Suppl 2","key":"2559_CR4","doi-asserted-by":"publisher","first-page":"ii41","DOI":"10.1136\/thx.2010.137000","volume":"65","author":"HE Davies","year":"2010","unstructured":"Davies HE, Davies RJO, Davies CWH, et al. Management of pleural infection in adults: british thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii41\u2013ii53. https:\/\/doi.org\/10.1136\/thx.2010.137000.","journal-title":"Thorax"},{"key":"2559_CR5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2214\/ajr.144.6.1189","volume":"144","author":"JL Westcott","year":"1985","unstructured":"Westcott JL. Percutaneous catheter drainage of pleural effusion and empyema. AJR Am J Roentgenol. 1985;144:1189\u201393. https:\/\/doi.org\/10.2214\/ajr.144.6.1189.","journal-title":"AJR Am J Roentgenol"},{"key":"2559_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMoa042473","volume":"352","author":"NA Maskell","year":"2005","unstructured":"Maskell NA, Davies CWH, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865\u201374. https:\/\/doi.org\/10.1056\/NEJMoa042473.","journal-title":"N Engl J Med"},{"key":"2559_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jtcvs.2006.09.038","volume":"133","author":"F Farjah","year":"2007","unstructured":"Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg. 2007;133:346\u201351. https:\/\/doi.org\/10.1016\/j.jtcvs.2006.09.038.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2559_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1164\/ajrccm.155.1.9001327","volume":"155","author":"D Bouros","year":"1997","unstructured":"Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291\u20135. https:\/\/doi.org\/10.1164\/ajrccm.155.1.9001327.","journal-title":"Am J Respir Crit Care Med"},{"key":"2559_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/ajrccm.159.1.9803094","volume":"159","author":"D Bouros","year":"1999","unstructured":"Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37\u201342. https:\/\/doi.org\/10.1164\/ajrccm.159.1.9803094.","journal-title":"Am J Respir Crit Care Med"},{"key":"2559_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1742-1241.2001.tb11156.x","volume":"55","author":"B Tuncozgur","year":"2001","unstructured":"Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658\u201360.","journal-title":"Int J Clin Pract"},{"key":"2559_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00408-015-9807-6","volume":"193","author":"C Alem\u00e1n","year":"2015","unstructured":"Alem\u00e1n C, Porcel JM, Alegre J, et al. Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study. Lung. 2015;193:993\u20131000. https:\/\/doi.org\/10.1007\/s00408-015-9807-6.","journal-title":"Lung"},{"key":"2559_CR12","doi-asserted-by":"publisher","unstructured":"Altmann ES, Crossingham I, Wilson S, et al. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019;CD002312. https:\/\/doi.org\/10.1002\/14651858.CD002312.pub4.","DOI":"10.1002\/14651858.CD002312.pub4"},{"key":"2559_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1012740","volume":"365","author":"NM Rahman","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518\u201326. https:\/\/doi.org\/10.1056\/NEJMoa1012740.","journal-title":"N Engl J Med"},{"issue":"4","key":"2559_CR14","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1097\/LBR.0000000000000400","volume":"24","author":"RM Shah","year":"2017","unstructured":"Shah RM, Krochmal R, Pickering EM, Burrows W, Sachdeva A. Diffuse alveolar hemorrhage as a complication of Intrapleural fibrinolytic therapy. J Bronchol Interv Pulmonol. 2017;24(4):e54\u2013e6. https:\/\/doi.org\/10.1097\/LBR.0000000000000400.","journal-title":"J Bronchol Interv Pulmonol"},{"key":"2559_CR15","first-page":"17","volume":"58","author":"MS Barthwal","year":"2016","unstructured":"Barthwal MS, Marwah V, Chopra M, et al. A five-year study of intrapleural fibrinolytic therapy in loculated pleural collections. Indian J Chest Dis Allied Sci. 2016;58:17\u201320.","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"2559_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2169\/internalmedicine.0060-22","volume":"62","author":"M Ugajin","year":"2023","unstructured":"Ugajin M, Yanoma S, Kani H. Intrapleural urokinase injection after medical thoracoscopy for empyema and complicated para-pneumonic effusion: a case series. Intern Med. 2023;62:571\u201376. https:\/\/doi.org\/10.2169\/internalmedicine.0060-22.","journal-title":"Intern Med"},{"key":"2559_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12890-022-02157-x","volume":"22","author":"J Taniguchi","year":"2022","unstructured":"Taniguchi J, Nakashima K, Matsui H, et al. The relationship between chest tube position in the thoracic cavity and treatment failure in patients with pleural infection: a retrospective cohort study. BMC Pulm Med. 2022;22:358. https:\/\/doi.org\/10.1186\/s12890-022-02157-x.","journal-title":"BMC Pulm Med"},{"key":"2559_CR18","doi-asserted-by":"publisher","first-page":"2000130","DOI":"10.1183\/13993003.00130-2020","volume":"56","author":"JP Corcoran","year":"2020","unstructured":"Corcoran JP, Psallidas I, Gerry S, et al. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study. Eur Respir J. 2020;56:2000130. https:\/\/doi.org\/10.1183\/13993003.00130-2020.","journal-title":"Eur Respir J"},{"key":"2559_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1378\/chest.13-1558","volume":"145","author":"NM Rahman","year":"2014","unstructured":"Rahman NM, Kahan BC, Miller RF, et al. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145:848\u201355. https:\/\/doi.org\/10.1378\/chest.13-1558.","journal-title":"Chest"},{"key":"2559_CR20","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1513\/AnnalsATS.201505-272OC","volume":"12","author":"HD White","year":"2015","unstructured":"White HD, Henry C, Stock EM, et al. Predicting long-term outcomes in pleural infections. RAPID score for risk stratification. Ann Am Thorac Soc. 2015;12:1310\u201316. https:\/\/doi.org\/10.1513\/AnnalsATS.201505-272OC.","journal-title":"Ann Am Thorac Soc"},{"key":"2559_CR21","doi-asserted-by":"publisher","first-page":"l5657","DOI":"10.1136\/bmj.l5657","volume":"367","author":"RJ Desai","year":"2019","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367:l5657. https:\/\/doi.org\/10.1136\/bmj.l5657.","journal-title":"BMJ"},{"key":"2559_CR22","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323:2417\u20138. https:\/\/doi.org\/10.1001\/jama.2020.7819.","journal-title":"JAMA"},{"key":"2559_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiology.169.1.3047789","volume":"169","author":"SG Silverman","year":"1988","unstructured":"Silverman SG, Mueller PR, Saini S, et al. Thoracic empyema: management with image-guided catheter drainage. Radiology. 1988;169:5\u20139. https:\/\/doi.org\/10.1148\/radiology.169.1.3047789.","journal-title":"Radiology"},{"key":"2559_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.37737\/ace.2.2_33","volume":"2","author":"H Yasunaga","year":"2020","unstructured":"Yasunaga H. Introduction to applied statistics\u2014chapter 1 propensity score analysis. Ann Clin Epidemiol. 2020;2:33\u20137. https:\/\/doi.org\/10.37737\/ace.2.2_33.","journal-title":"Ann Clin Epidemiol"},{"key":"2559_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/thx.2008.105080","volume":"64","author":"JD Chalmers","year":"2009","unstructured":"Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64:592\u201397. https:\/\/doi.org\/10.1136\/thx.2008.105080.","journal-title":"Thorax"},{"key":"2559_CR26","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661\u201379. https:\/\/doi.org\/10.1002\/sim.6607.","journal-title":"Stat Med"},{"key":"2559_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00408-016-9964-2","volume":"195","author":"JM Porcel","year":"2017","unstructured":"Porcel JM, Valencia H, Bielsa S. Manual intrapleural saline flushing plus urokinase: a potentially useful therapy for complicated parapneumonic effusions and empyemas. Lung. 2017;195:135\u20138. https:\/\/doi.org\/10.1007\/s00408-016-9964-2.","journal-title":"Lung"},{"key":"2559_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4329\/wjr.v9.i4.212","volume":"9","author":"B Li","year":"2017","unstructured":"Li B, Liu C, Li Y, et al. Computed tomography-guided catheter drainage with urokinase and ozone in management of empyema. World J Radiol. 2017;9:212\u20136. https:\/\/doi.org\/10.4329\/wjr.v9.i4.212.","journal-title":"World J Radiol"},{"key":"2559_CR29","doi-asserted-by":"publisher","first-page":"00084","DOI":"10.1183\/23120541.00084-2019","volume":"5","author":"B B\u00e9dat","year":"2019","unstructured":"B\u00e9dat B, Plojoux J, Noel J, et al. Comparison of intrapleural use of urokinase and tissue plasminogen activator\/DNase in pleural infection. ERJ Open Res. 2019;5:00084\u20132019. https:\/\/doi.org\/10.1183\/23120541.00084-2019.","journal-title":"ERJ Open Res"},{"key":"2559_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4046\/trd.2020.0018","volume":"84","author":"S Lee","year":"2021","unstructured":"Lee S, Lee H, Lee DH, et al. Fibrinolysis with lower dose urokinase in patients with complicated parapneumonic effusion. Tuberc Respir Dis. 2021;84:134\u20139. https:\/\/doi.org\/10.4046\/trd.2020.0018.","journal-title":"Tuberc Respir Dis"},{"key":"2559_CR31","doi-asserted-by":"publisher","unstructured":"Cameron RJ, Davies HRHR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2008;2CD002312. https:\/\/doi.org\/10.1002\/14651858.CD002312.pub3.","DOI":"10.1002\/14651858.CD002312.pub3"},{"key":"2559_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.11-3071","volume":"142","author":"S Janda","year":"2012","unstructured":"Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest. 2012;142:401\u201311. https:\/\/doi.org\/10.1378\/chest.11-3071.","journal-title":"Chest"},{"key":"2559_CR33","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1148\/radiol.2463070235","volume":"246","author":"DA Gervais","year":"2008","unstructured":"Gervais DA, Levis DA, Hahn PF, et al. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology. 2008;246:956\u201363. https:\/\/doi.org\/10.1148\/radiol.2463070235.","journal-title":"Radiology"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02559-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02559-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02559-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:03:19Z","timestamp":1689937399000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02559-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2559"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02559-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2961254\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"21 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was reviewed and approved by the Research Ethics Committee of Kameda Medical Center (#21\u2013091) in accordance with the Declaration of Helsinki of 1964 and all its subsequent amendments. The Ethics Committee of Kameda Medical Center waived the requirement for written informed consent owing to the retrospective nature of the study; participants were also given the option to opt-out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}